CAVU Biotherapies, Inc. — Form D
CAVU Biotherapies, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-17. The offering totals $1.5M, of which $75K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-03-17
- Form: D
- Accession: 0001696916-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $75K
- Remaining: $1.4M
- Investors: 2
- Date of first sale: 2017-03-06
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-282852
Issuer
- Name: CAVU Biotherapies, Inc.
- CIK: 0001696916
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 8285 El Rio, HOUSTON, TX, 77054
- Phone: 7133802758
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Colleen M O'Connor | Director | Houston, TX |
| Colleen M O'Connor | Executive Officer | Houston, TX |
| Colleen O'Connor | Director | HOUSTON, TX |
| Colleen O'Connor | Executive Officer | HOUSTON, TX |
Other filings by this issuer (1)
More